We want the experience of smoking, without the dangers that would replicate with cigarette related, and we wanted to do better than the nicotine replacement therapies currently on the market, said Jed Rose, director of the Duke Center for Nicotine and Smoking Cessation research where the technology is developed. He presented the data at the Society for Nicotine and Tobacco Research in Baltimore.

More research is needed to examine the safety and efficacy of prolonged use of the inhalation system, New Zealand Ltd in helping people smoking. Smoking. Rose says if all goes well, he anticipates the product could commercially available within three to five years.postal term children has a much higher risk for a clinically relevant behavior problems and is longer twice as often born as appointment children clinical ADHD also have.

Other articles from category "mental":

Random articles